| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |